Orthopedic digital x-ray firm EOS Imaging has received clearance from the U.S. Food and Drug Administration (FDA) for its hipEOS 3D hip arthroplasty planning software.
The software is based on EOS stereoradiographic 2D/3D imaging, according to the company. Developed by OneFit Medical, hipEOS allows surgeons to perform presurgical planning including hip implant selection and virtual positioning.
The software uses real-size 3D patient anatomical information obtained from the EOS exam to help physicians define implant size and preoperatively visualize the restoration expected from a total hip arthroplasty, the firm said.
EOS will officially launch hipEOS in the U.S. at the American Academy of Orthopedic Surgeons (AAOS) annual meeting, being held March 24-28, 2015, in Las Vegas.
